Our goal with any partnership is to simplify and improve the lives of people with diabetes by providing solutions that make a positive, daily difference.
Submit a partnership opportunity:
Business Development and Licensing
Addressing the Challenges of Diabetes Management through Collaboration
At Ascensia Diabetes Care we do not believe that the challenges of diabetes can be overcome by one company working alone. We need to work with multiple partners from different parts of the diabetes industry if we are to meet the changing needs of people living with diabetes. These collaborations are essential to the development of groundbreaking technologies for diabetes management and making them available for people across the world. We enter into mutually beneficial partnerships that use the expertise and skills of each partner to create the most effective collaboration that can help people with diabetes.
Our Current Partnerships
Our technology and commercial partners help us to create more effective diabetes management solutions or get existing solutions into the hands of more people with diabetes. We are proud of the collaborations we have with these current partners.
Digital Partnerships: enable the integration of best-in-class digital solutions with Ascensia's technologies, in addition to enabling commercial collaboration with Ascensia Diabetes Care. These partnerships allow Ascensia to broaden the digital diabetes management solutions we offer, and/or allow our diabetes technologies to reach a larger audience. The ultimate goal of these collaborations is to enable additional support to our customers through digital solutions.
Regional technology partnership to connect the CONTOUR®NEXT ONE meter with the Balansio mobile app (acquired by ProWellness), which includes a calculator for bolus insulin dosing for people with type 1 diabetes.
Global technology partnership with Glooko to integrate their data management platform with our CONTOUR®NEXT ONE and CONTOUR®PLUS ONE systems to allow blood glucose data to be accessed by patients via Glooko’s Mobile App and by HCPs via Glooko’s Clinic Data Upload products.
Regional collaboration in India to connect the CONTOUR®PLUS ONE meter to the GOQii disease management application that is part of their smart preventive health ecosystem which supports comprehensive diabetes management.
Regional collaboration in Asian markets to provide an offering for people with diabetes that is comprised of the CONTOUR®PLUS or CONTOUR®TS blood glucose monitoring systems, the Health2Sync app and a loyalty program for users, known as the Ascensia Customer Care Program.
Regional technology partnership in Russia and CIS (Commonwealth of Independent States) countries to integrate data from the CONTOUR®PLUS ONE with any Russian electronic medical records system, and telemedicine providers for physicians, care teams and biomedical engineers.
Global technology partnership to connect the CONTOUR®NEXT ONE and CONTOUR®PLUS ONE meters via Bluetooth to the Insulia® Diabetes Management Companion from Voluntis which can help calculate basal insulin dosing for people with type 2 diabetes.
Global collaboration with SNAQ's app-based solution that offers key insights on food and nutrition for people living with diabetes (PWDs), and Ascensia's CONTOUR® BGM portfolio and data management systems, to empower PWDs to make positive mealtime decisions.
Regional collaboration in the US enabling distribution of the CONTOUR®NEXT ONE blood glucose monitoring system by 9am.health to complement their all-in-one virtual diabetes care platform.
Insulin Delivery Partnerships: allow us to achieve one of two goals. Firstly, to connect our blood glucose meters to insulin pumps or other diabetes management devices, so they can use the highly accurate readings for calibration of continuous glucose monitors or dosing of insulin. We want to be the partner of choice for any device in the diabetes market that needs highly accurate blood glucose readings. Secondly, to provide entry into the insulin delivery space through collaboration with differentiated technologies, with the ultimate goal of bringing the benefits of automated insulin delivery to more people with diabetes.
Global alliance to exclusively co-develop and supply the CONTOUR®NEXT LINK and CONTOUR®PLUS LINK blood glucose meters that connect to the MiniMed® Paradigm and 6 Series pump systems (including the MiniMed® 630G and MiniMed® 670G) for seamless calibration and insulin dosing.
CGM Partnerships: enable us to build a long-term world-class continuous glucose monitoring (CGM) franchise. Through partnerships with companies who have created cutting edge CGM solutions for the diabetes community, we have established ourselves as a recognized player in this market, bringing CGM products to more people with diabetes.
Global agreement to commercialize and distribute the currently available Eversense CGM systems and future next-generation products in development.
Minority investment to support development and commercialization of Biolinq's innovative microneedle based intradermal sensor (biowearable) that is capable of measuring glucose and other metabolic analytes in real-time.
BGM Integration Partnerships: allow diabetes data that has been collected by the Bluetooth® enabled Ascensia blood glucose meters (BGMs) to be used by partner software and apps. The partners shown here are just a few examples of the many companies that have requested integration with our CONTOUR® wireless meters. We currently have BGM data integration agreements executed with over 180 partners. These partnerships simplify the lives of people with diabetes by providing the option for them to use their data with various software partners, in addition to our own CONTOUR®DIABETES app.
Regional collaboration in the US with integration of the CONTOUR®NEXT ONE blood glucose monitoring system by Current Health, as part of Best Buy Health, to provide a unique solution for healthcare organizations, combining cutting-edge technology and clinical expertise with retail scale and in-home support services.
